Trial Profile

A Phase 2, Single Dose, Open-Label, Exploratory Study to Investigate the Safety and Efficacy of OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 27 Mar 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pafolacianine (Primary)
Indications Adenocarcinoma; Lung cancer
Focus Diagnostic use
Sponsors On Target Laboratories

Most Recent Events

27 Jan 2020 Results presented in an On Target Laboratories Media Release.
27 Jan 2020 According to an On Target Laboratories media release, results were presented at the 56th Annual Meeting of the Society of Thoracic Surgeons (STS), held in New Orleans.
19 Aug 2019 According to an On Target Laboratories media release, the top-line data for this study will be available in the first half of 2020.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com